These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 25092159)
1. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients. Kim KJ; Kim SM; Lee YS; Chung WY; Chang HS; Park CS Ann Surg Oncol; 2015 Jan; 22(1):125-31. PubMed ID: 25092159 [TBL] [Abstract][Full Text] [Related]
2. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression. Khan M; Syed AA; Khan AI; Hussain SR; Urooj N Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398 [TBL] [Abstract][Full Text] [Related]
3. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
4. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
5. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547 [TBL] [Abstract][Full Text] [Related]
6. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma. Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258 [TBL] [Abstract][Full Text] [Related]
7. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma. Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma. Kim WY; Kim HY; Son GS; Bae JW; Lee JB J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486 [TBL] [Abstract][Full Text] [Related]
9. High recurrent rate of multicentric papillary thyroid carcinoma. Lin JD; Chao TC; Hsueh C; Kuo SF Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244 [TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582 [TBL] [Abstract][Full Text] [Related]
11. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506 [TBL] [Abstract][Full Text] [Related]
12. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation]. Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486 [TBL] [Abstract][Full Text] [Related]
13. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Grigsby PW; Reddy RM; Moley JF; Hall BL Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155 [TBL] [Abstract][Full Text] [Related]
14. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422 [TBL] [Abstract][Full Text] [Related]
15. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620 [TBL] [Abstract][Full Text] [Related]
16. Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment. Guy A; Hirsch D; Shohat T; Bachar G; Tirosh A; Robenshtok E; Shimon I; Benbassat CA J Clin Endocrinol Metab; 2014 Nov; 99(11):4167-73. PubMed ID: 25157544 [TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of prognostic factors predictive of lymph-node metastasis and recurrence in thyroid papillary microcarcinoma. Usluogullari CA; Onal ED; Ozdemir E; Ucler R; Kiyak G; Ersoy PE; Yalcin S; Güler G; Ersoy R; Cakir B Minerva Endocrinol; 2015 Mar; 40(1):15-22. PubMed ID: 24699706 [TBL] [Abstract][Full Text] [Related]
18. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy. Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin. Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210 [TBL] [Abstract][Full Text] [Related]
20. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]